Discovery of novel insomnia leads from screening traditional Chinese medicine database

References

• Alvarez Dolado, M., & Broccoli, V. (2011). GABAergic neuronal precursor grafting: Implications in brain regeneration and plasticity. Neural Plasticity, 2011. doi:10.1155/2011/384216
   Google Scholar
• Bocca, M. L., & Denise, P. (2000). Residual effects of hypnotics on disengagement of spatial attention. Journal of Psychopharmacology, 14, 401–405.
   PubMedGoogle Scholar
• Brejc, K., van Dijk, W. J., Klaassen, R. V., Schuurmans, M., van Der Oost, J., Smit, A. B., & Sixma, T. K. (2001). Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors. Nature, 411, 269–276.
   PubMed Web of Science ®Google Scholar
• Brooks, B. R., Brooks, C. L., 3rd, Mackerell, A. D., Jr, Nilsson, L., Petrella, R. J., Roux, B., … Karplus, M. (2009). CHARMM: The biomolecular simulation program. Journal of Computational Chemistry, 30, 1545–1614.
   PubMed Web of Science ®Google Scholar
• Buhr, A., & Sigel, E. (1997). A point mutation in the gamma2 subunit of gamma-aminobutyric acid type A receptors results in altered benzodiazepine binding site specificity. Proceedings of the National academy of Sciences of the United States of America, 94, 8824–8829.
   PubMedGoogle Scholar
• Chen, Y. C. (2007). The molecular dynamic simulation of zolpidem interaction with gamma aminobutyric acid type A receptor. Journal of the Chinese Chemical Society, 54, 653–658.
   Web of Science ®Google Scholar
• Chen, C. Y. C. (2008). Insights into the suanzaoren mechanism – From constructing the 3D structure of GABA-A receptor to its binding interaction analysis. Journal of the Chinese Institute of Chemical Engineers, 39, 663–671.
   Google Scholar
• Chen, C. Y. C. (2009). Chemoinformatics and pharmacoinformatics approach for exploring the GABA-A agonist from Chinese herb suanzaoren. Journal of the Taiwan Institute of Chemical Engineers, 40, 36–47.
   Web of Science ®Google Scholar
• Chen, C. Y. C. (2011). TCM Database@Taiwan: The world’s largest traditional Chinese medicine database for drug screening in silico. PLoS ONE, 6, e15939.
   PubMed Web of Science ®Google Scholar
• Chen, C. Y. C., Chen, Y. F., Wu, C. H., & Tsai, H. Y. (2008). What is the effective component in suanzaoren decoction for curing insomnia? Discovery by virtual screening and molecular dynamic simulation. Journal of Biomolecular Structure and Dynamics, 26, 57–64.
   PubMed Web of Science ®Google Scholar
• Chou, K. C., Watenpaugh, K. D., & Heinrikson, R. L. (1999). A model of the complex between cyclin-dependent kinase 5 and the activation domain of neuronal Cdk5 activator. Biochemical and Biophysical Research Communications, 259, 420–428.
   PubMed Web of Science ®Google Scholar
• Dundar, Y., Boland, A., Strobl, J., Dodd, S., Haycox, A., Bagust, A., ... Walley, T. (2004). Newer hypnotic drugs for the short-term management of insomnia: A systematic review and economic evaluation. Health Technology Assessment, 8, iii-x, 1–125.
   Google Scholar
• Fletcher, R. (1969). Optimization. New York: Academic Press.
   Google Scholar
• Fletcher, R. & Reeves, C. M. (1964). Function Minimization by Conjugate Gradients. The Computer Journal, 7, 149–154.
   Google Scholar
• Grunwald, C., Rundfeldt, C., Lankau, H. J., Arnold, T., Hofgen, N., Dost, R., … Unverferth, K. (2006). Synthesis, pharmacology, and structure–activity relationships of novel imidazolones and pyrrolones as modulators of GABA(A) receptors. Journal of Medicinal Chemistry, 49, 1855–1866.
   PubMedGoogle Scholar
• Kales, A., Scharf, M. B., Kales, J. D., & Soldatos, C. R. (1979). Rebound insomnia. A potential hazard following withdrawal of certain benzodiazepines. JAMA, 241, 1692–1695.
   PubMed Web of Science ®Google Scholar
• Kirkwood, C. K. (1999). Management of insomnia. Journal of American Pharmacists Association, 39, 688–696; quiz 713–714.
   Google Scholar
• Klausberger, T., Fuchs, K., Mayer, B., Ehya, N., & Sieghart, W. (2000). GABA(A) receptor assembly. Identification and structure of gamma(2) sequences forming the intersubunit contacts with alpha(1) and beta(3) subunits. Journal of Biological Chemistry, 275, 8921–8928.
   PubMedGoogle Scholar
• Kovacic, P., & Somanathan, R. (2009). Zolpidem, a clinical hypnotic that affects electronic transfer, alters synaptic activity through potential GABA receptors in the nervous system without significant free radical generation. Oxidative Medicine and Cellular Longevity, 2, 52–57.
   PubMed Web of Science ®Google Scholar
• Kuriyama, K., Hirouchi, M., & Nakayasu, H. (1993). Structure and function of cerebral GABAA and GABAB receptors. Neuroscience Research, 17, 91–99.
   PubMedGoogle Scholar
• Lader, M. H. (2001). Implications of hypnotic flexibility on patterns of clinical use. International Journal of Clinical Practice Supplement, 14–19.
   Google Scholar
• Li, B. F., Moree, W. J., Yu, J., Coon, T., Zamani-Kord, S., Malany, S., … Beaton, G. (2010). Selectivity profiling of novel indene H(1)-antihistamines for the treatment of insomnia. Bioorganic & Medicinal Chemistry Letters, 20, 2629–2633.
   PubMedGoogle Scholar
• Lin, T. L., & Song, G. (2011). Efficient mapping of ligand migration channel networks in dynamic proteins. Proteins, 79, 2475–2490.
   PubMed Web of Science ®Google Scholar
• Monchesky, T. C., Billings, B. J., & Phillips, R. (1986). Zopiclone: A new nonbenzodiazepine hypnotic used in general practice. Clinical Therapeutics, 8, 283–291.
   PubMedGoogle Scholar
• Moree, W. J., Li, B. F., Zamani-Kord, S., Yu, J., Coon, T., Huang, C., … Beaton, G. (2010). Identification of a novel selective H1-antihistamine with optimized pharmacokinetic properties for clinical evaluation in the treatment of insomnia. Bioorganic & Medicinal Chemistry Letters, 20, 5874–5878.
   PubMed Web of Science ®Google Scholar
• Nutt, D. J., & Stahl, S. M. (2010). Searching for perfect sleep: The continuing evolution of GABAA receptor modulators as hypnotics. Journal of Psychopharmacology, 24, 1601–1612.
   PubMed Web of Science ®Google Scholar
• Olsen, R. W., & Sieghart, W. (2009). GABA A receptors: Subtypes provide diversity of function and pharmacology. Neuropharmacology, 56, 141–148.
   PubMed Web of Science ®Google Scholar
• Patat, A., Paty, I., & Hindmarch, I. (2001). Pharmacodynamic profile of Zaleplon, a new non-benzodiazepine hypnotic agent. Human Psychopharmacology, 16, 369–392.
   PubMed Web of Science ®Google Scholar
• Pierce, M. W., Shu, V. S., & Groves, L. J. (1990). Safety of estazolam. The United States clinical experience. American Journal of Medicine, 88, 12S–17S.
   PubMedGoogle Scholar
• Rosenberg, R. P. (2006). Sleep maintenance insomnia: Strengths and weaknesses of current pharmacologic therapies. Annals of Clinical Psychiatry, 18, 49–56.
   PubMedGoogle Scholar
• Rudolph, U., & Knoflach, F. (2011). Beyond classical benzodiazepines: Novel therapeutic potential of GABAA receptor subtypes. Nature Reviews Drug Discovery, 10, 685–697.
   PubMed Web of Science ®Google Scholar
• Sarto-Jackson, I., & Sieghart, W. (2008). Assembly of GABA(A) receptors (Review). Molecular Membrane Biology, 25, 302–310.
   PubMed Web of Science ®Google Scholar
• Sigel, E., & Buhr, A. (1997). The benzodiazepine binding site of GABAA receptors. Trends in Pharmacological Sciences, 18, 425–429.
   PubMed Web of Science ®Google Scholar
• Ulrich, D., & Bettler, B. (2007). GABA(B) receptors: Synaptic functions and mechanisms of diversity. Current Opinion in Neurobiology, 17, 298–303.
   PubMed Web of Science ®Google Scholar
• Whiting, P. J. (2006). GABA-A receptors: A viable target for novel anxiolytics? Current Opinion in Pharmacology, 6, 24–29.
   PubMed Web of Science ®Google Scholar
• Winrow, C. J., Gotter, A. L., Cox, C. D., Tannenbaum, P. L., Garson, S. L., Doran, S. M., … Renger, J. J. (2012). Pharmacological characterization of MK-6096 – a dual orexin receptor antagonist for insomnia. Neuropharmacology, 62, 978–987.
   PubMed Web of Science ®Google Scholar
• Yang, S. C., Chang, S. S., Chen, H. Y., & Chen, C. Y. C. (2011). Identification of potent EGFR inhibitors from TCM Database@Taiwan. PLoS Computational Biology, 7, e1002189.
   PubMed Web of Science ®Google Scholar
• Yang, M. D., Lai, K. C., Lai, T. Y., Hsu, S. C., Kuo, C. L., Yu, C. S., … Chung, J. G. (2010). Phenethyl isothiocyanate inhibits migration and invasion of human gastric cancer AGS cells through suppressing MAPK and NF-kappa B signal pathways. Anticancer Research, 30, 2135–2143.
   PubMedGoogle Scholar